Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Tricaprilin by Cerecin for Infantile Spasm (West Syndrome): Likelihood of Approval
Tricaprilin is under clinical development by Cerecin and currently in Phase II for Infantile Spasm (West Syndrome). According to GlobalData,...